CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 157 filers reported holding CARA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $439,961 | -52.9% | 89,605 | +3.0% | 0.00% | -100.0% |
| Q4 2022 | $934,755 | +108.7% | 87,035 | +81.7% | 0.00% | – |
| Q3 2022 | $448,000 | +3.0% | 47,901 | +0.6% | 0.00% | – |
| Q2 2022 | $435,000 | -27.0% | 47,636 | -2.9% | 0.00% | -100.0% |
| Q1 2022 | $596,000 | -1.5% | 49,079 | -1.1% | 0.00% | – |
| Q4 2021 | $605,000 | -12.8% | 49,625 | +10.6% | 0.00% | – |
| Q3 2021 | $694,000 | -1.1% | 44,879 | -8.8% | 0.00% | – |
| Q2 2021 | $702,000 | -20.4% | 49,233 | +21.1% | 0.00% | – |
| Q1 2021 | $882,000 | +16.8% | 40,667 | -18.5% | 0.00% | – |
| Q4 2020 | $755,000 | +75.2% | 49,878 | +47.1% | 0.00% | – |
| Q3 2020 | $431,000 | -32.1% | 33,904 | -8.7% | 0.00% | – |
| Q2 2020 | $635,000 | +105.5% | 37,148 | +58.8% | 0.00% | – |
| Q1 2020 | $309,000 | -28.6% | 23,392 | -13.0% | 0.00% | – |
| Q4 2019 | $433,000 | -11.1% | 26,892 | +0.9% | 0.00% | – |
| Q3 2019 | $487,000 | +19.4% | 26,643 | +40.2% | 0.00% | – |
| Q2 2019 | $408,000 | -9.9% | 19,004 | -17.5% | 0.00% | – |
| Q1 2019 | $453,000 | +32.1% | 23,046 | -12.8% | 0.00% | – |
| Q4 2018 | $343,000 | -21.0% | 26,425 | +46.1% | 0.00% | – |
| Q3 2018 | $434,000 | -6.9% | 18,092 | -25.6% | 0.00% | – |
| Q2 2018 | $466,000 | +23.6% | 24,308 | -20.1% | 0.00% | – |
| Q1 2018 | $377,000 | -50.6% | 30,408 | -51.2% | 0.00% | -100.0% |
| Q4 2017 | $763,000 | +11.1% | 62,363 | +24.5% | 0.00% | 0.0% |
| Q3 2017 | $687,000 | -50.5% | 50,084 | -44.5% | 0.00% | 0.0% |
| Q2 2017 | $1,389,000 | +857.9% | 90,246 | +476.9% | 0.00% | – |
| Q4 2016 | $145,000 | +5.1% | 15,644 | -5.2% | 0.00% | – |
| Q3 2016 | $138,000 | +10.4% | 16,497 | -36.8% | 0.00% | – |
| Q2 2016 | $125,000 | +5.9% | 26,118 | +38.1% | 0.00% | – |
| Q1 2016 | $118,000 | -17.5% | 18,915 | +88.8% | 0.00% | – |
| Q3 2015 | $143,000 | -57.1% | 10,018 | -63.4% | 0.00% | – |
| Q2 2015 | $333,000 | +34.8% | 27,402 | +11.4% | 0.00% | – |
| Q1 2015 | $247,000 | +48.8% | 24,602 | +23.8% | 0.00% | – |
| Q3 2014 | $166,000 | – | 19,872 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,204,449 | $10,824 | 1.35% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,233,000 | $6,054,030 | 1.14% |
| Chescapmanager LLC | 1,160,392 | $5,698 | 0.90% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,732,375 | $8,505,961 | 0.22% |
| XTX Topco Ltd | 107,610 | $528,365 | 0.11% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 84,530 | $415,042 | 0.08% |
| PINNACLE ASSOCIATES LTD | 679,413 | $3,335,918 | 0.07% |
| PDT Partners, LLC | 102,010 | $500,869 | 0.07% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,370 | $9,797,267 | 0.05% |
| AXQ CAPITAL, LP | 27,760 | $136,302 | 0.05% |